 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News FDA Extends Review for Salix Diarrhea DrugMay 1, 2012 The Food and Drug Administration has extended by three months the review date for an experimental pill to treat HIV treatment-related diarrhea, according to Salix Pharmaceuticals, the drug's maker. FDA had been scheduled to review the drug, crofelemer, on June 5. Salix said in a statement that FDA said it needs more time for a full review, although it did not ask for any additional studies. Reuters 04.30.2012; Balaji Sridharan  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|
Email
Comments
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
